Form 4 for INCY Incyte
Accepted 2025-11-07 00:00:00 ET · period of report 2025-11-05 · accession 0001673776-25-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-11-07 | 2025-11-05 | INCY | Stein Steven H | EVP, Chief Medical Off | S - Sale+OE | $102.20 | -5,233 | 102.9K | -5% | -$534.8K |
| DM | 2025-11-07 | 2025-11-05 | INCY | Stein Steven H | EVP, Chief Medical Off | M - OptEx | $93.04 | +5,233 | 108.1K | +5% | +$486.9K |
| DM | 2025-11-07 | 2025-11-05 | INCY | Stein Steven H | EVP, Chief Medical Off | M - OptEx | $0.00 | -5,233 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-05 | S | D | 5,233 | $102.20 | 102,886 | D | — | — | (F1) This includes an aggregate of 100,327 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested. |
| 2 | Common | Common Stock | 2025-11-05 | M | A | 2,995 | $95.76 | 107,075 | D | — | — | |
| 3 | Common | Common Stock | 2025-11-05 | M | A | 1,194 | $83.83 | 104,080 | D | — | — | |
| 4 | Common | Common Stock | 2025-11-05 | M | A | 1,044 | $95.76 | 108,119 | D | — | — | |
| 5 | Derivative | Non-Qualified Stock Option (right to buy) | 2025-11-05 | M | D | 1,194 | $0.00 | 0 | D | $83.83 · — to 2026-07-14 | 1,194 Common Stock | (F2) Beginning July 15, 2016, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years. |
| 6 | Derivative | Incentive Stock Option (right to buy) | 2025-11-05 | M | D | 1,044 | $0.00 | 0 | D | $95.76 · — to 2026-01-06 | 1,044 Common Stock | (F3) Beginning January 7, 2016, options become exercisable in full on January 7, 2020. |
| 7 | Derivative | Non-Qualified Stock Option (right to buy) | 2025-11-05 | M | D | 2,995 | $0.00 | 0 | D | $95.76 · — to 2026-01-06 | 2,995 Common Stock | (F3) Beginning January 7, 2016, options become exercisable in full on January 7, 2020. |